145 related articles for article (PubMed ID: 18628599)
1. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection.
Ota H; Takashima Y; Matsumoto Y; Hayashi Y; Matsumoto Y
J Vet Med Sci; 2008 Jun; 70(6):589-93. PubMed ID: 18628599
[TBL] [Abstract][Full Text] [Related]
2. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
[TBL] [Abstract][Full Text] [Related]
3. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
4. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
5. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection.
Reiner SL; Zheng S; Wang ZE; Stowring L; Locksley RM
J Exp Med; 1994 Feb; 179(2):447-56. PubMed ID: 7905017
[TBL] [Abstract][Full Text] [Related]
6. Regulation of activated macrophage antimicrobial activities. Identification of lymphokines that cooperate with IFN-gamma for induction of resistance to infection.
Belosevic M; Davis CE; Meltzer MS; Nacy CA
J Immunol; 1988 Aug; 141(3):890-6. PubMed ID: 3135315
[TBL] [Abstract][Full Text] [Related]
7. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
8. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Conrad SM; Strauss-Ayali D; Field AE; Mack M; Mosser DM
Infect Immun; 2007 Feb; 75(2):653-65. PubMed ID: 17088347
[TBL] [Abstract][Full Text] [Related]
9. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.
Heinzel FP; Rerko RM; Ahmed F; Pearlman E
J Immunol; 1995 Jul; 155(2):730-9. PubMed ID: 7608551
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells.
Belkaid Y; Butcher B; Sacks DL
Eur J Immunol; 1998 Apr; 28(4):1389-400. PubMed ID: 9565379
[TBL] [Abstract][Full Text] [Related]
11. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
12. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
[TBL] [Abstract][Full Text] [Related]
13. Interaction of Macrophage Antigen 1 and CD40 Ligand Leads to IL-12 Production and Resistance in CD40-Deficient Mice Infected with Leishmania major.
Okwor I; Jia P; Uzonna JE
J Immunol; 2015 Oct; 195(7):3218-26. PubMed ID: 26304989
[TBL] [Abstract][Full Text] [Related]
14. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
Ricardo-Carter C; Favila M; Polando RE; Cotton RN; Bogard Horner K; Condon D; Ballhorn W; Whitcomb JP; Yadav M; Geister RL; Schorey JS; McDowell MA
Parasite Immunol; 2013 Dec; 35(12):409-20. PubMed ID: 23834512
[TBL] [Abstract][Full Text] [Related]
15. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response.
Hondowicz BD; Scharton-Kersten TM; Jones DE; Scott P
J Immunol; 1997 Nov; 159(10):5024-31. PubMed ID: 9366430
[TBL] [Abstract][Full Text] [Related]
17. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions.
Launois P; Gumy A; Himmelrich H; Locksley RM; Röcken M; Louis JA
J Immunol; 2002 May; 168(9):4628-35. PubMed ID: 11971011
[TBL] [Abstract][Full Text] [Related]
18. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major.
Wang ZE; Zheng S; Corry DB; Dalton DK; Seder RA; Reiner SL; Locksley RM
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12932-6. PubMed ID: 7809149
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma produced in vivo during the first two days is critical for resolution of murine Leishmania major infections.
Leiby DA; Schreiber RD; Nacy CA
Microb Pathog; 1993 Jun; 14(6):495-500. PubMed ID: 8412622
[TBL] [Abstract][Full Text] [Related]
20. Ability of macrophage subsets to transfer resistance to murine leishmaniasis is dependent on IL-12 production.
Doherty TM; Coffman RL
Eur J Immunol; 1999 Feb; 29(2):522-9. PubMed ID: 10064067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
